RPL Mergers advises Haplo (UK) on its sale to market-leading cloud platform, Cayuse (USA).
RPL Mergers has advised the shareholders of Haplo, a leading research management solutions and SaaS provider in the UK, on their sale to Cayuse, based in the USA, for an undisclosed sum.
This acquisition comes on the heels of another year of growth that included the launch of the industry’s first purpose-built and cloud-native research platform. Supported by the recent investment by Primus Capital, Cayuse continues to pursue its mission to help research organizations worldwide advance their impact on science, discovery and society.
“We’re excited about the potential this combination of Haplo’s innovative researcher solutions and our end-to-end research suite brings to delivering long term value to the entire global research community.” said CEO Matt McLellan. “In addition, having a UK-based presence will enable us to continue to improve our service and support to our growing customer base in the middle east and southeast Asia, as well as for our US customers with global research teams.”
“For our Haplo customers, this merger of two great teams will allow us to provide world-class support and service while increasing their access to Cayuse’s full range of products and platform for research administration,” said Haplo co-founder Jennifer Summers. “We’re also thrilled to introduce our researcher-centric solutions to new markets where Cayuse is already the leader in electronic research administration systems.”
As research has become more global, this acquisition further enables Cayuse to be well positioned to support global collaboration and connectedness across the research ecosystem. Ultimately the beneficiaries are research teams at universities, hospital and health care organizations, pharmaceutical companies, and across government agencies who will be able to connect, collaborate and manage research operations via a single global platform regardless of geography, size or scale of their operations.
Timothy Buckeridge of RPL Mergers added: “We were pleased to be able to work with Ben and Jennifer on the sale of Haplo to Cayuse, Haplo’s IP and higher education focus are key aspects of what drove this cross-border deal.”